Nucl Med Mol Imaging
October 2021
A 65-year-old male patient with a past medical history of prostate adenocarcinoma presented with biochemical recurrence (prostate-specific antigen level of 5.91 mg/L). F-FACBC PET/CT was acquired to evaluate the disease recurrence and metastasis.
View Article and Find Full Text PDF